[Abstract Only] Randomized Trial: Patients with COPD Exacerbation and Low Eosinophil Count May be Treated with Shorter Corticosteroid Treatment

Eosinophil-guided corticosteroid therapy in patients admitted to hospital with COPD exacerbation (CORTICO-COP): a multicentre, randomised, controlled, open-label, non-inferiority trial – The Lancet Respiratory Medicine (link to abstract – $ for full-text)

Commentary: 2 Minute Medicine Rewind May 20, 2019 (4^th Summary)

See also: Video Summary – Medwire News (free audio)

Related Commentary on Twitter

Presenting now at #ATS2019 @atscommunity—Eosinophil-guided corticosteroid therapy in patients admitted to hospital with #COPD exacerbation (CORTICO-COP): a multicentre, randomised, controlled, open-label, non-inferiority trial https://t.co/YqUlX54gc5 pic.twitter.com/Bw1n9Tuink

— The Lancet Respiratory Medicine (@LancetRespirMed) May 20, 2019